Senti Biosciences (SNTI) Payables (2021 - 2025)
Senti Biosciences' quarterly Payables came in at $5.4 million in Q4 2025, up 268.23% year-on-year from $1.5 million in Q4 2024, and up 4.92% quarter-over-quarter from $5.1 million in Q3 2025.
Senti Biosciences has reported Payables for 5 years, with the latest figure at $5.4 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 268.23% year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (up 268.23% YoY), and the FY2025 full-year result was $5.4 million, up 268.23% from the prior year.
- Payables for Q4 2025 stood at $5.4 million, up from $5.1 million in the prior quarter.
- The five-year high for Payables was $12.6 million in Q4 2022, with the low at $28.0 in Q1 2021.
- Average Payables over 5 years is $4.1 million, with a median of $3.8 million recorded in 2025.
- Year-over-year, Payables surged 14015194.12% in 2022 and slumped 76.34% in 2024.
- Tracing SNTI's Payables over 5 years: stood at $5.3 million in 2021, then jumped by 135.9% to $12.6 million in 2022, then slumped by 52.87% to $5.9 million in 2023, then slumped by 75.47% to $1.5 million in 2024, then soared by 268.23% to $5.4 million in 2025.
- The last three Payables figures came in at $5.4 million (Q4 2025), $5.1 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 5.93 Mn |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 12.58 Mn |
| Sep 30, 2022 | 11.91 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Sep 30, 2021 | 85.00 |
| Jun 30, 2021 | 4,513.00 |
| Mar 31, 2021 | 28.00 |